Sort
48,018 grants matching “immunotherapy”
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana
$1,395,641Roger L Shapiro · Harvard School Of Public Health · U01 · FY2022 · AI
Accelerate cellular immunotherapy development for treatment of life-threatening childhood disorders
$1,395,617Julie R Park · Seattle Children'S Hospital · U01 · FY2022 · TR
Nanosystems Biology Cancer Center
$1,393,912James R. Heath · Institute For Systems Biology · U54 · FY2017 · CA
Basis for Success of Multidrug-Resistant Enterobacteriaceae
$1,393,455Frank Deleo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
The Johns Hopkins University - Uganda Clinical Trials Unit
$1,392,989Mary Glenn Fowler · Johns Hopkins University · UM1 · FY2025 · AI
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
$1,392,864Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · P50 · FY2018 · CA
Comprehensive SDSU/UCSD Cancer Center Partnership 1 of 2
$1,392,737Elizabeth A Klonoff · San Diego State University · U54 · FY2008 · CA
Immunobiology and Immunotherapy of Pediatric Cancer
$1,392,377Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Advanced Technologies - National Center for Image Guided Therapy (AT-NCIGT)
$1,391,424Clare M Tempany · Brigham And Women'S Hospital · P41 · FY2022 · EB
Advanced Technologies - National Center for Image Guided Therapy (AT-NCIGT)
$1,391,424Clare M Tempany · Brigham And Women'S Hospital · P41 · FY2024 · EB
Advanced Technologies - National Center for Image Guided Therapy (AT-NCIGT)
$1,391,424Clare M Tempany · Brigham And Women'S Hospital · P41 · FY2023 · EB
Improving the Outcome of Patients with Chronic Myeloid Leukemia Through Medi
$1,390,873Jorge E Cortes · University Of Tx Md Anderson Can Ctr · P01 · FY2010 · CA
Accelerate cellular immunotherapy development for treatment of life-threatening childhood disorders
$1,390,827Julie R Park · Seattle Children'S Hospital · U01 · FY2021 · TR
Next Generation GPC2-CARs for Medulloblastoma
$1,390,720Crystal Mackall · Stanford University · UG3 · FY2024 · CA
Next Generation GPC2-CARs for Medulloblastoma
$1,390,720Crystal Mackall · Stanford University · UG3 · FY2025 · CA
Active Immune Therapy and HAART for HIV-1 Infection
$1,390,708University Of Pennsylvania · P01 · FY2001 · AI
PROSTATE CANCER IMMUNOTHERAPY BY TARGETING DENDRITIC CELLS IN VIVO USING RECEPTOR-SPECIFIC APTAMER CONJUGATED TO PROSTATE STEM CELL ANTIGEN (PSCA)-EN
$1,390,595Duke University · · FY2010 · Department of Defense
Multiscale Analysis of Immune Responses
$1,389,263Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Heat Shock Protein and Thermal Therapy of Cancer
$1,389,197Roswell Park Cancer Institute Corp · P01 · FY2005 · CA
Role of co-receptor modified cells in HIV infection
$1,388,771Carl H. June · University Of Pennsylvania · U01 · FY2016 · AI
Establishing the role of MMP9 in amyloid-immunotherapy-induced ARIA
$1,388,218Donna M. Wilcock · Indiana University Indianapolis · RF1 · FY2022 · NS
Regulation And Function Of Retroelements
$1,388,000Henry L. Levin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD
Extracellular Vesicles (EVs) and Genes in the Biology and Therapy of Gliomas
$1,387,951Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2017 · CA
Cellular & Inflammatory Pathways in Ashtma & Allergic Diseases: From IgE to Cells
$1,387,837Lawrence Barry Schwartz · Virginia Commonwealth University · U19 · FY2008 · AI
Cancer-cell specific therapy: photo-immunotherapy
$1,387,661Hisataka Kobayashi · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA